2016 Conference
    Home
    • 2016 Conference
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2015 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2014 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2013 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2012 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Accommodation
      • Exhibition
      • Photos
    • 2011 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
      • Photos
    • Archive 2005 - 2010
        About us
        2015 Archive Presentation
        AbstractBiography
        Smoking cessation outcomes of an intensive tobacco treatment program within mental health and addictions services


        Click here to download the presentation (Powerpoint or viewer needed)
        Author(s)

        Chizimuzo Okoli and Milan Khara

        Presenter(s)

        Dr Chizimuzo Okoli  Assistant Professor, University of Kentucky College of Nursing, Lexington, USA

        Dr Milan Khara  Clinical Director, Vancouver General Hospital Smoking Cessation Clinic, Canada

        Abstract

        Background and objectives: Individuals with mental and/or substance use disorders are disproportionately affected by tobacco use, related disease, and mortality. This study provides smoking cessation outcomes of smokers with mental and/or substance use disorders referred to an intensive tobacco treatment program within mental health and addictions service settings in Vancouver, Canada.
        Methods:  The intervention combines 8-weeks of behavioural counseling and an additional (optional) 18-weeks of support group with pharmacotherapy for smoking cessation.  A retrospective analysis examined program participation data (N=1075) between September 2007 to March 2012. Seven-day point-prevalence of smoking abstinence (verified by expired carbon monoxide) was assessed at end-of-treatment.

        Results: In the intent-to-treat analysis 23% (249/1075) achieved cessation at end-of-treatment. Among those completing the program (i.e., finished at least 8-weeks of behavioural counseling), 40% (249/623) achieved smoking cessation. Stopping smoking for 6-months or longer at the last attempt, lower nicotine dependence scores at baseline, and greater duration in the program were significant predictors of end-of-treatment smoking cessation.

        Conclusions:  If provided with evidence-based approaches to smoking cessation, smokers with mental and/or substance use disorders are able to stop smoking. The provision of tobacco treatment within mental health and addictions services can support these populations in their cessation efforts.



        Source of funding: Health Canada.

        Declaration of interest: Dr Chizimuzo Okoli has received consultation fees from Vancouver Coastal Health Authority in the past 3 years.

        Dr Milan Khara has received consultation fees from Pfizer and Johnson & Johnson (makers of smoking cessation medications) in the last three years. All other authors report no conflicts of interest.

         
        Abstract
        Join our mailing list